Journal ArticleCancers · June 1, 2021
Chronic acid reflux causes cellular damage and inflammation in the lower esophagus. Due to these irritating insults, the squamous epithelium is replaced by metaplastic epithelium, which is a risk factor for the development of esophageal adenocarcinoma (EAC ...
Full textCite
Journal ArticleProstate Cancer Prostatic Dis · May 2019
BACKGROUND: To evaluate efficacy and morbidity prospectively in a contemporary multi-institutional salvage radical prostatectomy (SRP) series. METHODS: Forty-one men were enrolled between 1997 and 2006, who suffered biopsy-proven recurrent prostate cancer ...
Full textLink to itemCite
Journal ArticleInt J Urol · August 2016
OBJECTIVES: To study the effect of end-expiratory pressure used during anesthesia on blood loss during radical prostatectomy. METHODS: We evaluated 247 patients who underwent either radical retropubic prostatectomy or robot-assisted laparoscopic prostatect ...
Full textLink to itemCite
Journal ArticleJournal of Clinical Oncology · February 10, 2012
7 Background: The initial report of the Selenium and Vitamin E Cancer Prevention Trial (SELECT) found no reduction in risk of prostate cancer with either selenium or vitamin E supplements but a non-statistically significant incre ...
Full textCite
Journal ArticleJ Clin Oncol · February 10, 2012
34 Background: Despite a substantial effort to study the clinical significance of perineural invasion in prostate biopsies (PNIb) its prognostic significance remains controversial. The limited data on perineural invasion in radical prostatectomy (RP) speci ...
Link to itemCite
Journal ArticleJ Clin Oncol · February 10, 2012
7 Background: The initial report of the Selenium and Vitamin E Cancer Prevention Trial (SELECT) found no reduction in risk of prostate cancer with either selenium or vitamin E supplements but a non-statistically significant increase in prostate cancer risk ...
Link to itemCite
Journal ArticleJ Clin Oncol · February 10, 2012
34 Background: Despite a substantial effort to study the clinical significance of perineural invasion in prostate biopsies (PNIb) its prognostic significance remains controversial. The limited data on perineural invasion in radical prostatectomy (RP) speci ...
Full textLink to itemCite
Journal ArticleJAMA · October 12, 2011
CONTEXT: The initial report of the Selenium and Vitamin E Cancer Prevention Trial (SELECT) found no reduction in risk of prostate cancer with either selenium or vitamin E supplements but a statistically nonsignificant increase in prostate cancer risk with ...
Full textLink to itemCite
Journal ArticleJ Sex Med · October 2011
INTRODUCTION: The association between early and late phase sexual health-related quality of life (HRQoL) following radical prostatectomy (RP) is unclear. Moreover, factors that predict either early or late sexual HRQoL decline have not been fully investiga ...
Full textLink to itemCite
Journal ArticleCancer · September 1, 2011
BACKGROUND: A survival benefit has been observed with salvage radiation therapy (RT) for prostate-specific antigen (PSA) failure after radical prostatectomy (RP) in men with rapid rises in PSA doubling time (DT, < 6 months). Whether such a benefit exits in ...
Full textLink to itemCite
Journal ArticleBJU Int · December 2010
OBJECTIVE: To investigate whether salvage radiation therapy (RT) for prostate-specific antigen (PSA) failure can provide the same result as adjuvant RT, which decreases the risk of all-cause mortality (ACM) for men with positive margins (R1), or extra-caps ...
Full textLink to itemCite
Journal ArticleCancer · April 15, 2010
BACKGROUND: This report evaluated whether biochemical recurrence (BCR) as a time-dependent covariate (t) after radical prostatectomy (RP) for prostate cancer was associated with the risk of death and whether salvage therapy with radiotherapy (RT) and/or ho ...
Full textLink to itemCite
Journal ArticleJ Urol · November 2009
PURPOSE: We clarified whether men older than 70 years have a higher risk of prostate cancer and poorer survival in the early and late prostate specific antigen eras. MATERIALS AND METHODS: A cohort of 4,561 men who underwent radical prostatectomy were stra ...
Full textLink to itemCite
Journal ArticleJ Natl Med Assoc · July 2009
BACKGROUND: Individual variation in circulating insulinlike growth factor-1 (IGF1) and its major binding protein, insulinlike growth factor binding protein-3 (IGFBP3), have been etiologically linked to several chronic diseases, including some cancers. Fact ...
Full textLink to itemCite
Journal ArticleJAMA · January 7, 2009
CONTEXT: Secondary analyses of 2 randomized controlled trials and supportive epidemiologic and preclinical data indicated the potential of selenium and vitamin E for preventing prostate cancer. OBJECTIVE: To determine whether selenium, vitamin E, or both c ...
Full textLink to itemCite
Journal ArticleCancer Epidemiol Biomarkers Prev · December 2008
BACKGROUND: Prostate cancer affects one of six men during their lifetime. Dietary factors are postulated to influence the development and progression of prostate cancer. Low-fat diets and flaxseed supplementation may offer potentially protective strategies ...
Full textLink to itemCite
Journal ArticleJ Natl Med Assoc · July 2007
Carrying the cytosine-adenosine (CA)19 repeat polymorphism in insulin-like growth factor-1 (IGF1) is associated with lower serum proteins and decreased prostate cancer risk. Carrying the -202A/C genotype in insulin-like growth factor binding protein-3 (IGF ...
Link to itemCite
Journal ArticleEur Urol · March 2007
OBJECTIVE: We analysed total hospital costs by comparing minimally invasive surgery (MIS) procedures, such as laparoscopic cryoablation (LCA), laparoscopic partial nephrectomy (LPN), and hand-assisted laparoscopic nephrectomy (HALN), with conventional surg ...
Full textLink to itemCite
Journal ArticleUrology · February 2007
OBJECTIVES: To evaluate the financial implications of how the costs of new minimally invasive surgery such as laparoscopic robotic prostatectomy (LRP) and cryosurgical ablation of the prostate (CAP) technologies compare with those of conventional surgery. ...
Full textLink to itemCite
Journal ArticleProstate Cancer Prostatic Dis · 2006
To determine the timing and patterns of late recurrence after radical prostatectomy (RP) alone or RP plus adjuvant radiotherapy (RT). Between 1970 and 1983, 159 patients underwent RP for newly diagnosed adenocarcinoma of the prostate and were found to have ...
Full textLink to itemCite
Journal ArticleUrology · July 2005
OBJECTIVES: To characterize supplement use within a sample population of men diagnosed with prostate cancer. METHODS: A census of men diagnosed with prostate cancer at Duke University Medical Center from 1997 to 2002 (n = 1402) was mailed a survey that asc ...
Full textLink to itemCite
Journal ArticleCancer Epidemiol Biomarkers Prev · February 2005
We investigated the relationship between the insulin-like growth factor-1 (IGF1) cytosine-adenine repeat (CA)(19) polymorphism located upstream of the gene's transcription start site, the insulin-like growth factor binding protein-3 (IGFBP3) -202 A/C promo ...
Full textLink to itemCite
Journal ArticleJ Natl Cancer Inst · January 19, 2005
Prostate cancer continues to be a major health threat, especially among African American men. The Selenium and Vitamin E Cancer Prevention Trial (SELECT), which opened on July 25, 2001, was planned to study possible agents for the prevention of prostate ca ...
Full textLink to itemCite
Journal ArticleJ Natl Compr Canc Netw · January 2005
Urothelial tumors represent a spectrum of diseases with a range of prognosis. After a diagnosis is established at any point within the urothelial tract, the patient remains at risk for developing a new lesion at a different or the same location and at a si ...
Link to itemCite
Journal ArticleUrology · May 2004
OBJECTIVES: Dietary factors may influence the prostate and have an impact on prostatic growth and disease. A small number of studies have suggested that flaxseed-supplemented, fat-restricted diets may thwart prostate cancer growth in both animals and human ...
Full textLink to itemCite
Journal ArticleCancer Res · December 15, 2001
Featured Publication
The pathophysiological mechanism(s) by which androgen independence develops in prostate cancer remains to be determined. The identification in many prostate cancer specimens of a mutant androgen receptor, T877A, with altered ligand specificity has provided ...
Link to itemCite
Journal ArticleUrology · July 2001
Featured Publication
OBJECTIVES: Dietary fat and fiber affect hormonal levels and may influence cancer progression. Flaxseed is a rich source of lignan and omega-3 fatty acids and may thwart prostate cancer. The potential effects of flaxseed may be enhanced with concomitant fa ...
Full textLink to itemCite
Journal ArticleWorld J Urol · June 2000
Featured Publication
The medical management of hormone-refractory prostate cancer remains difficult and largely palliative. The development of effective antineoplastic agents has been frustrated by difficulty in the establishment of satisfactory objective response criteria for ...
Full textLink to itemCite
Journal ArticleCancer Epidemiol Biomarkers Prev · March 2000
Featured Publication
Prostatic carcinoma is the leading cancer among American men, yet few risk factors have been established. Although increased androgen levels have long been associated with both prostatic carcinoma and baldness, to date no studies have shown an association ...
Link to itemCite
Journal ArticleCurr Opin Urol · May 1999
As a result of the recent resurgence of interest in interstitial brachytherapy, extended follow-up studies of early experience in this field are now being reported. However, such outcomes must be evaluated within the context of recent comprehensive assessm ...
Full textLink to itemCite
Journal ArticleCancer · July 15, 1998
BACKGROUND: In the U.S., prostate carcinoma mortality is greatest among African Americans. In North Carolina, the state with the fourth largest population of African Americans, the prostate carcinoma mortality rate is 2.5 times greater among African Americ ...
Full textLink to itemCite
Journal ArticleCancer J Sci Am · 1998
PURPOSE: Activity has been reported in phase II single-center, open-label studies after administration of low-dose recombinant interferon gamma-1b (rIFN-gamma) to patients with metastatic renal cell carcinoma, with an overall objective response proportion ...
Link to itemCite
Journal ArticleOncogene · December 18, 1997
Progression of prostate cancer from an androgen sensitive to androgen insensitive tumor has previously been shown to be accompanied by a change in alternative splicing of fibroblast growth factor receptor 2 (FGF-R2) in a rat model of prostate cancer. This ...
Full textLink to itemCite
Journal ArticleJ Urol · October 1996
PURPOSE: Intestinal metaplasia of the urothelium occurs in chronically irritated retained urinary segments and can progress to enteric adenocarcinoma. We present a unique clinical experience with a closed segment ureter from a dysplastic kidney draining ec ...
Link to itemCite
Journal ArticleJ Urol · May 1996
PURPOSE: Several reports have shown that cells with p53 mutations display increased resistance to ionizing radiation, a treatment often used clinically for localized prostate carcinoma. MATERIALS AND METHODS: Totals of 18 post-irradiated locally recurrent ...
Link to itemCite
Journal ArticleCancer · September 1, 1995
BACKGROUND: Treatment with interleukin-2 (IL-2) and lymphokine-activated killer cells (LAK) resulted in responses in some patients with advanced renal cell carcinoma (RCC). However, the relative therapeutic benefit of the addition of LAK to IL-2 was unknow ...
Full textLink to itemCite
Journal ArticleSurg Oncol Clin N Am · April 1995
The development of new technologies has stimulated a crusade of screening for earlier detection of prostate cancer. This effort has resulted in controversy regarding its clinical use in this format. Until randomized clinical screening trials define the val ...
Link to itemCite
Journal ArticleSurg Oncol Clin N Am · April 1995
The genetic alterations associated with prostate carcinogenesis, its progression, and the emergence of androgen independence gradually are being defined. This article focuses on a number of genetic defects that have been identified in prostate cancer, spec ...
Link to itemCite
Journal ArticleSurg Oncol Clin N Am · April 1995
Sexually transmitted human papillomaviruses (HPV) are linked to both benign and malignant lesions of the genitourinary tract. Evidence links oncogenic HPV types with carcinomas of the penis and urethra. An association with other common sites of urologic ma ...
Link to itemCite
Journal ArticleJ Urol · February 1994
While a strong association between oncogenic human papillomaviruses and squamous cell cancers of the genital tract (penis, urethra and cervix) is known to exist, there is substantial controversy regarding the association of human papillomaviruses and cance ...
Full textLink to itemCite
Journal ArticleCancer Res · January 15, 1994
An in vivo study of cisplatin (CDDP) and 5-fluorouracil (5FU) cytotoxicity was performed using a multidose matrix with a human bladder transitional cell carcinoma xenograft tumor line (DU4284) tested by subrenal capsule assay in 154 nude mice (NM-SRCA). St ...
Link to itemCite
Journal ArticleJ Urol · January 1994
Using polymerase chain reaction with type-specific human papillomavirus type 16 and 18 primers, and general primers screening for 9 other genotypes, we analyzed archival surgical specimens of urethral carcinoma from 18 women (17 with invasive cancer and 1 ...
Full textLink to itemCite
Journal ArticleAm J Clin Pathol · September 1993
In this second review article of a two-part series on adenocarcinoma of the prostate, both established and experimental tissue prognosticators for adenocarcinoma of the prostate will be discussed. Consideration should be given to tissue indicators of progn ...
Full textLink to itemCite
Journal ArticleHum Pathol · September 1993
The expression of tenascin, an extracellular matrix glycoprotein, was studied in three human prostatic carcinoma cell lines by Northern and Western blot analyses and in human prostate tissues by immunohistochemistry and Western blot analysis. All three car ...
Full textLink to itemCite
Journal ArticleJ Urol · July 1993
Alterations of the p53 gene are among the most frequent genetic lesions in a variety of human malignancies. Their role in prostate cancer is, however, unclear. We have analyzed 10 primary and two metastatic human prostate carcinomas as well as 3 prostate c ...
Full textLink to itemCite
Journal ArticleEur Urol · 1993
The retropubic approach has recently become the method of choice for radical prostatectomy. This has been particularly evident since the 1970s, when open staging lymphadenectomy became an important part of the diagnostic workup, as both procedures could be ...
Full textLink to itemCite
Journal ArticleEur Urol · 1993
Radical prostatectomy can be performed either with a retropubic or perineal approach. While the former has enjoyed popularity in recent years, perineal prostatectomy has undergone a substantial resurgence because of interest in laparoscopic pelvic lymphade ...
Full textLink to itemCite
Journal ArticleJ Urol · January 1993
Primary squamous cell carcinoma of the prostate is an extremely uncommon malignancy, accounting for less than 1% of all prostatic cancers. We report on 2 patients with primary squamous cell carcinoma of the prostate: 1 with organ-confined disease and 1 wit ...
Full textLink to itemCite
Journal ArticleUrol Clin North Am · November 1992
Multimodal therapy for locally advanced bladder carcinoma is being pursued in a wide diversity of protocols at this same time. While a number of innovative approaches are being explored, neoadjuvant and adjuvant chemotherapy in conjunction with cystectomy ...
Link to itemCite
Journal ArticleCancer Res · September 15, 1992
Human papillomaviruses (HPV), especially genotypes 16 and 18, are probable effectors of human urogenital malignancies. Although the male urethra is a proposed reservoir of HPV transmission, the association between HPV and squamous cell carcinoma (SCC) of t ...
Link to itemCite
Journal ArticleSouth Med J · June 1992
Interleukin-2 is a promising new immunotherapeutic antineoplastic agent, but it can cause severe multiorgan toxicity. Although dermatologic toxicity is seen in most patients receiving IL-2 therapy, it is usually manifested as pruritus and an erythematous m ...
Full textLink to itemCite
Journal ArticleUrology · April 1992
Scrotal leiomyomas of the tunica dartos are extremely rare and usually misdiagnosed. A case of a pedunculated mass observed expectantly over thirty years demonstrates the benign oncologic natural history of this lesion despite its capability for substantia ...
Full textLink to itemCite
Journal ArticleJ Urol · April 1992
The Penrose drain internally tethered by a fascial suture is a surgical complication with medical and legal implications. Correction of this problem usually has required open reexploration. A technique of endoscopic release of such a drain through the drai ...
Full textLink to itemCite
Journal ArticleJ Immunother (1991) · April 1992
High-dose recombinant interleukin-2 (rIL-2) results in tumor responses in patients with metastatic renal cell carcinoma ranging from 9 to 31%. Continuous infusion regimens of rIL-2 may be less toxic and may result in greater in vivo lymphokine-activated ki ...
Full textLink to itemCite
Journal ArticleInt J Cancer · March 12, 1992
Human papillomaviruses (HPV), particularly types 16 and 18, may be carcinogenic effectors in a variety of human lower-genital-tract malignancies. Using the highly sensitive technique of differential polymerase chain reaction (D-PCR) with amplimers from the ...
Full textLink to itemCite
Journal ArticleJ Urol · March 1992
P53 is a tumor suppressor gene that has been implicated in the molecular genetics of many human malignancies. Nucleotide alterations, most commonly single point mutations, have been shown not only to abrogate the p53 suppressor function but also to contrib ...
Full textLink to itemCite
Journal ArticleHematol Oncol Clin North Am · February 1992
A substantial amount of investigation has been performed seeking to exploit the considerable technologic sophistication of automated flow cytometry for the management of bladder cancer. Although there is likely only a modest value for ploidy analysis of so ...
Link to itemCite
Journal ArticleJ Urol · January 1992
Human papilloma viruses (HPV) have been implicated in the pathogenesis of a variety of malignancies, especially in carcinomas of the female genital tract. Recently, based on observations using the polymerase chain reaction amplification assay, HPV types 16 ...
Full textLink to itemCite
Journal ArticleAm J Surg Pathol · December 1991
Histologic grade, DNA ploidy, and percentage tumor area were assessed in prostatectomy specimens from 73 patients with clinical stage B adenocarcinoma of the prostate and analyzed for their value as predictors of tumor progression. Further, the relationshi ...
Full textLink to itemCite
Journal ArticleJ Urol · November 1991
Using an in vivo assay of tumor cytotoxicity (the subrenal capsule assay in nude mice), two therapeutic strategies for the treatment of advanced human transitional cell carcinoma have been evaluated: 1) the use of 5-fluorouracil in combination with cisplat ...
Full textLink to itemCite
Journal ArticleSemin Oncol · October 1991
We have treated 17 patients with 5-fluorouracil (5-FU, 300 mg/m2/d by continuous ambulatory infusion for 8 weeks) and interferon alfa-2b (escalating doses to cohorts of three to five patients, given subcutaneously on a daily schedule at 2.0, 3.5, 5.0, and ...
Link to itemCite
Journal ArticleJ Urol · September 1991
A new human prostate adenocarcinoma cell line (DuPro-1) has been established from the athymic nude mouse supported xenograft DU5683. This was accomplished by embedding dispersed xenograft cells in 0.1 by 5.0 cm. spaghetti-like strands of Basement Membrane ...
Full textLink to itemCite
Journal ArticleCancer · September 1, 1991
Adenoid cystic carcinoma (ACC) of the breast is a rare histologic type of breast cancer associated with a good prognosis. A woman who earlier had a pulmonary metastasis surgically resected 6 years postmastectomy developed clinically symptomatic bleeding fr ...
Full textLink to itemCite
Journal ArticleWorld Journal of Urology · March 1, 1991
The records of all testicular cancer patients evaluated and treated at our medical center during two consecutive 9-year periods were reviewed and analyzed for prognostic factors, particularly the impact of cisplatin-based combination chemotherapy. The data ...
Full textCite
Journal ArticleJ Urol · November 1990
A total of 441 stage T1-2N0M0 and 11 stage T1-2N0M0 cancer patients with an elevated acid phosphatase level only, and 18 stage T1-2N+M0 cancer patients underwent radical prostatectomy. Analysis of the 441 stage T1-2N0M0 cancer patients demonstrated that fa ...
Full textLink to itemCite
Journal ArticleJ Urol · October 1990
The antitumor efficacy and host toxicity of dipyridamole (DP), methotrexate (MTX) and cisplatin (CDDP) alone and combined were evaluated in a nude mouse supported human bladder cancer model. Single agent post treatment tumor volume growth ratio [TGR] value ...
Full textLink to itemCite
Journal ArticleInt J Cancer · August 15, 1990
Multicellular tumor spheroids (MTS) provide a closer in vitro correlate to in vivo malignancy than do conventional monolayer cultures; while simulating many parameters of in vivo growth, MTS systems provide those perquisites (i.e., experimental control, ec ...
Full textLink to itemCite
Journal ArticleJ Urol · June 1990
A group of 159 patients previously reported as having margins positive for disease after radical prostatectomy with or without adjunctive postoperative radiation was reanalyzed to determine whether the reported benefit did indeed exist. Upon re-examination ...
Full textLink to itemCite
Journal ArticleJ Urol · March 1990
Flow cytometry was used to analyze deparaffinized primary renal cell carcinoma specimens from 106 patients to evaluate deoxyribonucleic acid ploidy as a predictor of disease progression and survival. Of these specimens 62 (58%) demonstrated aneuploid stem ...
Full textLink to itemCite
Journal ArticleJ Urol · March 1990
In an effort to determine the impact of a delayed diagnosis in testicular cancer the records of 148 patients with a known interval of delay were reviewed. The over-all mean symptomatic interval of this population was 21.1 weeks and did not change significa ...
Full textLink to itemCite
Journal ArticleWorld Journal of Urology · March 1, 1990
Of 244 patients with testicular cancer who were treated at our medical center between 1970 and 1987, 7 (2.9%) refused all or a portion of their cancer therapy. All refusers died of cancer, and 6 of the 7 deaths were directly attributable to the refusal. Re ...
Full textCite
Journal ArticleWorld Journal of Urology · March 1, 1990
Once the only therapy available for locoregional disease extension, the approriate role for surgical management by retroperitoneal lymphadenectomy (RPND) of nonseminomatous germ cell testicular cancer is now being redefined in an algorithm of management co ...
Full textCite
Journal ArticleUrol Res · 1990
The combination of tumor necrosis factor (TNF) and etoposide (ETP) was evaluated for potential cytotoxic efficacy against a human renal cell carcinoma xenograft using an in vivo assay employing an athymic mouse host with tumor implanted a the subrenal caps ...
Full textLink to itemCite
Journal ArticleJ Urol · December 1989
Of 244 patients with testis cancer seen between January 1970 and December 1987 (mean followup 70 months) 88 (36.1%) experienced 1 or more early complications (within 1 year), while 16 (6.6%) had a late (greater than 1 year) complication. Chemotherapy-relat ...
Full textLink to itemCite
Journal ArticleJ Urol · August 1989
A family of triple hybridomas secreting hybrid monoclonal antibodies has been developed in our laboratory. The hybrid monoclonal antibodies exhibit bimolecular specificity towards both antigenic determinants on the prostate carcinoma cell surface as well a ...
Full textLink to itemCite
Journal ArticleJ Biol Response Mod · June 1989
While additive in vitro antitumor cytotoxicity has been observed with tumor necrosis factor (TNF) in combination with cytotoxic agents, particularly actinomycin D (AMD), the critical issue of potentially enhanced host toxicity has not been assessed with su ...
Link to itemCite
Journal ArticleBr J Urol · March 1989
A series of 145 patients with T1-2NOMO prostatic carcinoma underwent radical prostatectomy. Specimens were analysed by Gleason sum and categorised according to whether the disease was organ-confined, specimen-confined or margin-positive. The failure of tre ...
Full textLink to itemCite
Journal ArticleWorld Journal of Urology · March 1, 1989
Radical prostatectomy has been the mainstay of treatment for localized prostate cancer for over 50 years, but its value has been controversial. This report evaluates the impact of this therapeutic modality by assessing the value of various prognostic strat ...
Full textCite
Journal ArticleArch Surg · January 1989
Although studies done in tissue culture (in vitro) have shown synergism between recombinant human tumor necrosis factor (rhTNF) and chemotherapeutic agents, whether such synergism exists in a complex in vivo environment with acceptable toxic side effects h ...
Full textLink to itemCite
Journal ArticleCancer · November 15, 1988
Limbic encephalitis (encephalopathy) is a rare paraneoplastic syndrome which rarely responds to antineoplastic therapy. The authors report the first case of limbic encephalopathy associated with testicular carcinoma and the first histologically confirmed e ...
Full textLink to itemCite
Journal ArticleJ Urol · October 1988
Flow cytometry was used to evaluate 88 deparaffinized radical prostatectomy specimens to compare deoxyribonucleic acid ploidy in prostatic adenocarcinoma as a predictor of disease progression with other well documented predictors of clinical recurrence. An ...
Full textLink to itemCite
Journal ArticleJ Urol · September 1988
A total of 76 patients (18 with stage A1 and 58 with stage A2 cancer) underwent radical perineal prostatectomy. No perioperative deaths occurred and no patient suffered rectal injury or was incontinent postoperatively. Five patients (3 with stage A1 and 2 ...
Full textLink to itemCite
Journal ArticleJ Urol · August 1988
Segmental cystic disease of the kidney is a rare entity with the gross and microscopic features of autosomal dominant polycystic kidney disease localized to only a portion of a kidney. We report a renal-sparing management approach to a patient in whom a mu ...
Full textLink to itemCite
Journal ArticleJ Urol · July 1988
Pathological data from 321 patients who underwent radical prostatectomy or cystoprostatectomy with a diagnosis of prostatic adenocarcinoma were reviewed. Of these specimens 4 (1.2 per cent) demonstrated histopathological findings consistent with prostatic ...
Full textLink to itemCite
Journal ArticleCancer · November 1, 1987
Cisplatin is a recognized neurotoxic agent that commonly causes ototoxicity and peripheral neuropathy. In conjunction with characteristic peripheral neuropathy, two patients treated with high-dose cisplatin developed Lhermitte's sign, a manifestation of po ...
Full textLink to itemCite
Journal ArticleJ Urol · April 1987
Intraoperative penile tumescence during endoscopic surgery is a troublesome complication that often is refractory to recommended methods of management. We report a new approach of pharmacological management with intracorporeal penile injections of phenylep ...
Full textLink to itemCite
Journal ArticleJ Urol · February 1987
The management of erectile impotence in renal transplant patients remains problematical. The enhanced risk of surgical infection in this immunosuppressed patient population must be addressed if prosthetic implantation is contemplated. A case of Fournier's ...
Full textLink to itemCite
Journal ArticleJ Urol · November 1986
A total of 143 patients underwent radical prostatectomy. Surgical specimens were evaluated with respect to local extent of disease, Gleason grade of the primary and relative nuclear roundness of the surgical specimen. The probability of disease control in ...
Full textLink to itemCite
Journal ArticleCancer Treat Rep · June 1986
The treatment of prostate carcinoma with the epipodophyllotoxin derivative etoposide was studied in a multi-institutional phase II trial. An iv dose schedule of 130 mg/m2 daily for 3 days every 3 weeks was utilized. A total of 36 patients were evaluable; t ...
Link to itemCite
Journal ArticleUrology · February 1986
Supravesical calcification noted on conventional radiography when associated with a bladder lesion has been considered nearly pathognomonic of the uncommon lesion, urachal adenocarcinoma. As the case reported here demonstrates, stippled microscopic calcifi ...
Full textLink to itemCite
Journal ArticleCancer Immunol Immunother · 1986
Cultured prostate carcinoma cells incubated in the presence of a novel hybrid immunotoxin and ricin A chain exhibited synergy with the chemotherapeutic drugs vinblastine, methotrexate, and bleomycin. No cooperative effect was noted with adriamycin. Under c ...
Full textLink to itemCite
Journal ArticleJ Urol · December 1985
The use of single pigtail soft silicone self-retaining ileal conduit stents appears to have particular value in the perioperative management of patients with a Kock pouch continent urinary diversion. Stenting provides greater assurance of sustained interna ...
Full textLink to itemCite
Journal ArticleJ Urol · December 1985
Chylothorax is an uncommon condition rarely seen in urological oncology and it is an extremely rare complication of prostatic carcinoma. Such a case is described in which successful palliative management with a combination of chemotherapy and radiation the ...
Full textLink to itemCite
Journal ArticleWorld Journal of Urology · September 1, 1985
The variable sensitivity of similar tumors to cytotoxic drugs from patient to patient would suggest a potential role for a reliable laboratory method to identify effective as well as ineffective chemotherapeutic agents. While the known moderately responsiv ...
Full textCite
Journal ArticleCancer Treat Rep · June 1985
We have used cell fusion technology to produce second-generation hybridomas which secrete a population of murine monoclonal antibodies (MABs), a portion of which are bifunctional antibodies. The bifunctional hybrid MABs produced are capable of recognizing ...
Link to itemCite
Journal ArticleJ Urol · May 1985
While standard commercially available pigtail ureteral stents are used commonly in the obstructed patient, particularly when metastatic disease has been identified, our recent experience suggests caution in the use of such stents for patients with ileal co ...
Full textLink to itemCite
Journal ArticleCancer Res · December 1984
The cross-linking and inactivation of the plasma protein alpha 2-macroglobulin by cis-diamminedichloroplatinum(II) (cisplatin; Gonias, S. L., and Pizzo, S. V. J. Biol. Chem., 256: 12478-12484, 1981) was used to study platinum(II)-protein binding in the pre ...
Link to itemCite
Journal ArticleCancer Research · December 1, 1984
The cross-linking and inactivation of the plasma protein αz-macroglobulin by cis-diamminedichloroplatinum(ll) (cisplatin; Gonias, S. L., and Pizzo, S. V. J. Biol. Chem., 256: 12478-12484,1981) was used to study platinum(ll)-protein binding in the presence ...
Cite
Journal ArticleAm J Med · September 1984
A 66-year-old man with metastatic prostatic carcinoma treated with high-dose (5 mg) diethylstilbestrol therapy underwent orchiectomy to allow discontinuation of estrogen. An extensive ecchymosis developed postoperatively in an area covered by elastic dress ...
Full textLink to itemCite
Journal ArticleWorld Journal of Urology · March 1, 1984
The development of effective chemotherapy regimens for germ-cell carcinoma has mandated a reassessment of the management of testicular seminoma, since patients with advanced seminoma respond poorly to radiotherapy. Although traditional radiotherapy regimen ...
Full textCite
Journal ArticleCancer Immunol Immunother · 1984
The alpha-Pro 13-secreting hybridoma was produced by immunizing mice with an equal mixture of PC-3, DU145, and LNCaP established prostatic carcinoma cell lines. The specificity of alpha-Pro 13 monoclonal antibody was evaluated by the criteria of differenti ...
Full textLink to itemCite
Journal ArticleUrology · June 1982
Needle biopsy of the prostate has been widely practiced for more than twenty-five years, whereas transrectal aspiration biopsy, first described fifty years ago, has not. We describe our experience using the transrectal aspiration biopsy and correlate the r ...
Full textLink to itemCite
Journal ArticleJ Urol · September 1979
The rare complication of massive hematuria secondary to metastatic infiltrating adenocarcinoma of the lung to the kidney was managed with steel coil therapeutic embolization. The angiographic and pathologic picture as well as the advantages of this therape ...
Full textLink to itemCite
Journal ArticleTrans Am Assoc Genitourin Surg · 1979
Nine patients with a variety of surface transitional cell neoplastic lesions received topical mitomycin-C. The results of treatment were encouraging, all patients responding completely or partially. Based on this experience the authors are participating in ...
Link to itemCite
Journal ArticleJ Biol Chem · August 10, 1975
The two stages in the activation of human plasminogen by urokinase have been examined kinetically in order to evaluate the significance of each stage in the activation process. The cleavage of the preactivation peptide from the NH2 terminus of native plasm ...
Link to itemCite